Sigilon Therapeutics, Inc. License Agreements

7 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Fifth Amendment to Exclusive Patent License Agreement, by and between Massachusetts Institute of Technology and Sigilon Therapeutics, Inc., dated September 17, 2021
License Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2021
Sixth Amendment to Exclusive Patent License Agreement, by and between Massachusetts Institute of Technology and Sigilon Therapeutics, Inc., dated February 1, 2022
License Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2022
Fourth Amendment to Exclusive Patent License Agreement, by and between Massachusetts Institute of Technology and Sigilon Therapeutics, Inc., dated December 10, 2020
License Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2021
Third Amendment to Exclusive Patent License Agreement, by and between Massachusetts Institute of Technology and Sigilon Therapeutics, Inc., dated November 6, 2019
License Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
Second Amendment to Exclusive Patent License Agreement, by and between Massachusetts Institute of Technology and Sigilon Therapeutics, Inc., dated August 9, 2018
License Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
First Amendment to Exclusive Patent License Agreement, by and between Massachusetts Institute of Technology and Sigilon Therapeutics, Inc., dated February 2, 2017
License Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
Exclusive Patent License Agreement, by and between Massachusetts Institute of Technology and Sigilon Therapeutics, Inc., dated February 8, 2016
License Agreements
Sigilon Therapeutics, Inc.
Biotechnology
MA
2020